- Recommendation ID
- TA216/1
- Question
- Research should be carried out to compare the clinical effectiveness of bendamustine with chlorambucil at the higher dose used in the Chronic Lymphocytic Leukaemia Trial 4 (CLL4).
- Any explanatory notes
(if applicable) - None.
Source guidance details
- Comes from guidance
- Bendamustine for the first-line treatment of chronic lymphocytic leukaemia
- Number
- TA216
- Date issued
- February 2011
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |